Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies

NCT00496860 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Progressive Metastatic Malignancies

Interventions

BIOLOGICAL: ALT-801

Sponsor

Altor BioScience